4//SEC Filing
Quirk Gerald E 4
Accession 0001209191-23-049420
CIK 0001556263other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:05 PM ET
Size
5.7 KB
Accession
0001209191-23-049420
Insider Transaction Report
Form 4
Quirk Gerald E
Chief Legal Officer
Transactions
- Award
Restricted Stock Units
2023-09-12+30,000→ 30,000 total→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F2]These RSUs will vest as to one third (1/3rd) of the shares underlying the award on September 30, 2024 and as to an additional one third (1/3rd) of such shares at the end of each successive year thereafter.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001479603
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 4:05 PM ET
- Size
- 5.7 KB